ARQT - Arcutis Biotherapeutics appoints Verrica Pharma's CMO July, 27 2020 11:39 AM Arcutis Biotherapeutics Inc. Arcutis Biotherapeutics (ARQT +4.3%) names Verrica Pharma's (VRCA -2.8%) Patrick Burnett as Chief Medical Officer (CMO), effective August 1.More news on: Arcutis Biotherapeutics, Inc., Verrica Pharmaceuticals Inc., Healthcare stocks news, Stocks on the move, Read more ...